Inspire Investing’s Genomic Health, Inc. GHDX Stock Holding History

Inspire Investing’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,601	Closed	-$55K	–	851
2017 Q4	$55K	Buy	+1,601	New	+$51K	0.05%	653

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Inspire Investing's GHDX Position: Q1 2018 in Review

Inspire Investing sold out of Genomic Health, Inc. (GHDX) in Q1 2018, closing a stake of 1,601 shares — an estimated $55K sold.

Inspire Investing first reported a position in GHDX in Q4 2017 and held it in 1 quarter. The position peaked at $55K in Q4 2017. 134 funds tracked by Wall St. Rank hold GHDX as of Q1 2018.

Inspire Investing reported no remaining Genomic Health, Inc. position as of Q1 2018 after selling out during the quarter.
Inspire Investing sold 1,601 Genomic Health, Inc. shares in Q1 2018, an estimated $55K.
Inspire Investing first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 1 quarter.
Inspire Investing's Genomic Health, Inc. position peaked at $55K in Q4 2017.
134 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2018.

Based on Inspire Investing's 13F filing for Q1 2018, filed 13 Apr 2018.